SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-17-007382
Filing Date
2017-08-10
Accepted
2017-08-10 16:51:27
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1702293_10q.htm 10-Q 310690
2 EXHIBIT 10.1 t1702293_ex10-1.htm EX-10.1 131893
3 EXHIBIT 31.1 t1702293_ex31-1.htm EX-31.1 10013
4 EXHIBIT 31.2 t1702293_ex31-2.htm EX-31.2 10106
5 EXHIBIT 32.1 t1702293_ex32-1.htm EX-32.1 3620
6 EXHIBIT 32.2 t1702293_ex32-2.htm EX-32.2 3908
  Complete submission text file 0001571049-17-007382.txt   2223672

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cycc-20170630.xml EX-101.INS 295592
8 XBRL SCHEMA FILE cycc-20170630.xsd EX-101.SCH 27321
9 XBRL CALCULATION FILE cycc-20170630_cal.xml EX-101.CAL 27956
10 XBRL DEFINITION FILE cycc-20170630_def.xml EX-101.DEF 77720
11 XBRL LABEL FILE cycc-20170630_lab.xml EX-101.LAB 267074
12 XBRL PRESENTATION FILE cycc-20170630_pre.xml EX-101.PRE 164991
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 171022054
SIC: 2834 Pharmaceutical Preparations